Ecolab's first quarter reported diluted EPS was $0.97, a decrease of 4%, while adjusted diluted EPS was $1.13, a 10% increase. Reported sales increased by 2%. The company is not providing earnings forecasts due to the fluid nature of COVID-19 impacts.
Reported diluted EPS decreased by 4% to $0.97.
Adjusted diluted EPS increased by 10% to $1.13, excluding special gains and charges and discrete tax items.
Reported sales increased by 2%.
Acquisition adjusted fixed currency sales also increased by 2%, with growth in Institutional and Healthcare & Life Sciences segments offsetting a 3% decline in Upstream Energy.
The company expects the major COVID-19 impacts will be felt over the next few quarters and will be net unfavorable on both our top and bottom lines for the year. Our second quarter will likely see the largest sales impact as we realize both lower consumption, particularly in our restaurant and hotel segments, and channel destocking. These factors remain very fluid, and as a consequence, we are unable to reliably model our sales and therefore we will not be providing earnings forecasts.
Visualization of income flow from segment revenue to net income